Selected Grants
MK-0616
Clinical TrialCo Investigator · Awarded by Merck Sharp & Dohme LLC. · 2024 - 2030Endocrinology and Metabolism Training Program
Inst. Training Prgm or CMEMentor · Awarded by National Institute of Diabetes and Digestive and Kidney Diseases · 2024 - 2029Stimulating Access to Research in Residency (StARR) - NHLBI
Inst. Training Prgm or CMEPreceptor · Awarded by National Heart, Lung, and Blood Institute · 2018 - 2028Mechanisms linking the Branched-Chain alpha-Keto Acid regulatory network to the pathogenesis of NASH
ResearchCo Investigator · Awarded by National Institute of Diabetes and Digestive and Kidney Diseases · 2023 - 2028Mechanisms Connecting Dysregulated Branched-Chain Alpha-Ketoacid Metabolism to Cardiac Dysfunction
ResearchPrincipal Investigator · Awarded by National Heart, Lung, and Blood Institute · 2022 - 2027RECOVER-ENERGIZE
Clinical TrialPrincipal Investigator · Awarded by DCRI-Duke-Site · 2024 - 2026Multi-component Lifestyle Intervention to improve cardiovascular outcomes in chronic kidney disease (R61/R33)
ResearchCo Investigator · Awarded by National Institutes of Health · 2025 - 2026The Branched Chain Ketoacid Dehydrogenase Kinase-Phosphatase System as a New Regulatory Node in Myocardial Fuel Section
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2018 - 2023cvMOBIUS
Clinical TrialPrincipal Investigator · Awarded by Amgen, Inc. · 2020 - 2021Manipulation of BCAA Metabolism for Therapy of Diabetes and its Co-morbidities
ResearchCo-Principal Investigator · Awarded by Eli Lilly and Company · 2017 - 2018External Relationships
- AstraZeneca
- Elsevier Inc.
- M3 global research
This faculty member (or a member of their immediate family) has reported outside activities with the companies, institutions, or organizations listed above. This information is available to institutional leadership and, when appropriate, management plans are in place to address potential conflicts of interest.